US Department of Justice asks for Gambro files
This article was originally published in Clinica
The US Department of Justice (DOJ) has subpoenaed the US dialysis subsidiary of Swedish Gambro, Gambro Healthcare. Gambro Healthcare has been requested to supply documents relating to its business activities and operations. The company said that it intends to co-operate with the request and added that it may be part of the ongoing investigation into the renal care market in the US.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.